The clinical value of teicoplanin therapeutic drug monitoring

CPD Infection

Volumn 2, Issue 3, 2001, Pages 93-97

  Darley, E S R ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Antibiotic assay; Teicoplanin; Therapeutic drug monitoring

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; TEICOPLANIN; VANCOMYCIN;

BACTERIAL ARTHRITIS; BACTERIAL ENDOCARDITIS; BACTERIAL INFECTION; CLINICAL TRIAL; CONCENTRATION RESPONSE; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; DRUG HALF LIFE; DRUG INDICATION; DRUG MONITORING; DRUG PROTEIN BINDING; DRUG USE; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEMATOLOGIC DISEASE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NEPHROTOXICITY; NONHUMAN; OUTCOMES RESEARCH; PATIENT MONITORING; PHARMACODYNAMICS; PHARMACOLOGICAL PARAMETERS; POPULATION RISK; POSTANTIBIOTIC EFFECT; PRACTICE GUIDELINE; PREDICTION; REVIEW; STAPHYLOCOCCUS INFECTION; TREATMENT PLANNING; UNITED KINGDOM;

EID: 0035183291     PISSN: 14681668     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Pharmacokinetics of single- and multiple-dose teicoplanin in healthy volunteers
2. Experience with outpatient intravenous teicoplanin therapy for chronic osteomyelitis
3. Teicoplanin and oral ciprofloxacin as outpatient treatment of infective episodes in patients with indwelling central venous catheters and haematological malignancy
4. Teicoplanin pharmacokinetics in healthy volunteers after administration of intravenous loading and maintenance doses
5. Effects of dosage, peak and through concentrations in serum, protein binding and bactericidal rate of efficacy of teicoplanin in a rabbit model of endocarditis
6. British Society for Antimicrobial Chemotherapy Standardized Disc Sensitivity Testing Method
7. Retrospective review of serum teicoplanin concentrations in clinical trials and their relationship to clinical outcome
8. Comparison of the in vitro antibacterial activity of teicoplanin and vancomycin against gram-positive cocci
9. Comparative effect of protein binding on the killing activities of teicoplanin and vancomycin
10. In-vitro comparison of the post-antibiotic effect of vancomycin and teicoplanin
11. The post-antibiotic effect of teicoplanin: Monotherapy and combination studies
12. Pharmacokinetics of teicoplanin upon multiple dose intravenous administration to normal healthy male volunteers
13. Serum monitoring of teicoplanin
14. Efficacy and safety of teicoplanin plus rifampicin in the treatment bacteraemic infections caused by Staphylococcus aureus
15. The efficacy of teicoplanin in the treatment of endocarditis caused by Gram-positive bacteria
16. Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patients
17. Treatment of bone, joint and vascular-access-associated gram-positive bacterial infections with teicoplanin
18. Comparison of efficacy and safety of teicoplanin in gram-positive infections: A multicentre study
19. Teicoplanin in the treatment of bone and joint infections
20. Infective endocarditis and glycopeptides
21. Teicoplanin therapy for Staphylococcus aureus septicaemia: Relationship between pre-dose serum concentrations and outcome
22. Pharmacokinetics of teicoplanin upon multiple-dose intravenous administration of 3, 12 and 30 milligrams per kilogram of body weight to healthy male volunteers
23. A critical review of the dosage of teicoplanin in Europe and the USA
24. Teicoplanin assay - Why bother?